tiprankstipranks
Advertisement
Advertisement
CareDx raises FY26 revenue view to $447M-$465M from $420M-$444M
PremiumThe FlyCareDx raises FY26 revenue view to $447M-$465M from $420M-$444M
6d ago
CareDx to Acquire Naveris, Expanding Oncology Diagnostics
Premium
Company Announcements
CareDx to Acquire Naveris, Expanding Oncology Diagnostics
6d ago
CareDx reports Q1 EPS 34c, consensus 13c
Premium
The Fly
CareDx reports Q1 EPS 34c, consensus 13c
6d ago
Closing Bell Movers: JB Hunt up 2% after Q1 earnings beat
PremiumThe FlyClosing Bell Movers: JB Hunt up 2% after Q1 earnings beat
19d ago
CareDx up 20% at $21 after Q1 pre-announcement, Lab Products divestment
Premium
The Fly
CareDx up 20% at $21 after Q1 pre-announcement, Lab Products divestment
19d ago
CareDx to divest Lab Products unit to EuroBio for $170M cash consideration
Premium
The Fly
CareDx to divest Lab Products unit to EuroBio for $170M cash consideration
19d ago
AI Models Turn Cautious on CareDx, Flagging Profitability and Reimbursement Risks
PremiumAI Analyst RatingsAI Models Turn Cautious on CareDx, Flagging Profitability and Reimbursement Risks
1M ago
CareDx Downgraded by AI Models as Profitability and Reimbursement Risks Weigh on Outlook
Premium
AI Analyst Ratings
CareDx Downgraded by AI Models as Profitability and Reimbursement Risks Weigh on Outlook
1M ago
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
Premium
Ratings
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100